Cardinal Health Inc
1CAH
Company Profile
Business description
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Contact
7000 Cardinal Place
DublinOH43017
USAT: +1 614 757-5000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Distribution
Fiscal Year End
30 June 2026
Employees
57,700
Stocks News & Analysis
stocks
Sales shine but broader macro outlook darkens for this ASX share
US stores are struggling, but our investment thesis hinges on the Australian rollout.
stocks
Chart of the Week: US equity market trading at an attractive discount
The latest from our Chief US Market Strategist.
stocks
Undervalued ASX share retains wide moat rating despite regulatory pressures
Proposed price regulation impacts our fair value.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,168.90 | 43.80 | 0.48% |
| CAC 40 | 8,205.71 | 58.16 | -0.70% |
| DAX 40 | 23,744.10 | 336.53 | -1.40% |
| Dow JONES (US) | 47,769.34 | 140.58 | -0.29% |
| FTSE 100 | 10,583.05 | 25.83 | -0.24% |
| HKSE | 25,752.40 | 140.62 | -0.54% |
| NASDAQ | 22,595.00 | 39.99 | -0.18% |
| Nikkei 225 | 55,895.32 | 413.10 | -0.73% |
| NZX 50 Index | 13,273.81 | 19.87 | 0.15% |
| S&P 500 | 6,772.69 | 10.12 | -0.15% |
| S&P/ASX 200 | 8,973.20 | 57.80 | 0.65% |
| SSE Composite Index | 3,966.17 | 28.83 | -0.72% |